3Salih W, Schembri S, Chalmers JD. Simplification of the IDSA/ ATS criteria for severe CAP using meta-analysis and observational data[J]. Eur Respir J, 2014, 43(3) : 842-851. DOI: 10. 1183/ 09031936. 00089513.
4Cao B, Zhao C J, Yin YD, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China [ J ]. Clin Infect Dis, 2010, 51 (2) : 189-194. DOI: 10. 1086/653535.
5Liu Y, Chen M, Zhao T, et al. Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban population[ J]. BMC Infect Dis, 2009, 9: 31. DOI: 10. 1186/1471-2334-9-31.
6Von Baum H, Wehe T, Marre R, et al. Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa : Diagnosis, incidence and predictors [ J ]. Eur Respir J, 2010, 35 (3): 598-605. DOI: 10. 1183/09031936. 00091809.
7Einhorn AE, Neuhauser MM, Bearden DT, et al. Extended- spectrum beta-laetamases: frequency, risk factors, and outcomes [ J]. Pharmacotherapy, 2002, 22(1 ): 14-20.
9Qu JX, Gu L, Pu ZH, et al. Viral etiology of community-acquired pneumonia among adolescents and adults with mild or moderate severity and its relation to age and severity[ J]. BMC Infect Dis, 2015, 15: 89. DOI: 10. 1186/s12879-015-0808-0.
10Gao HN, Lu HZ, Cao B, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection[J]. N Engl J Med, 2013, 368(24) : 2277-2285. DOI: 10. 1056/NEJMoa1305584.
3Hoban DJ,Doern GV,Fluit AC,et al.Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae,Haemophilus influenzae,and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clinical Infectious Diseases,2001,32 Suppl 2:S81-93.
4Clinical and Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement.Wayne:Clinical and Laboratory Standards Institute,2011.
5Wise R,Hart T,Cars O,et al. Antimicrobial resistance. Is a major threat to public health.BMJ,1998,317:609-610.
6Cars O,Mosltad S,Melander A.Variation in antibiotic use in the European Union.Lancet,.2001,357:1851-1853.
7Otter JA,French GL. Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection.J Hosp Infect,2011,79:189-193.
8Sun HL,Yang QW,Xu YC,et al.Resistance study of community respiratory pathogens isolated in China from 2005 to 2007.Zhonghua Yi Xue Za Zhi,2009,89:2983-2987.
9Inoue M, Farrell DJ, Kaneko K, et al. Antimicrobial Susceptibility of Respiratory Tract Pathogens in Japan during PROTEKT Years 1-5 (1999-2004).Microb Drug Resist,2008,14:109-117.
10Goldstein EJ,Citron DM,Hudspeth M,et al.In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans. Antimicrob Agents Chemother,1997,41:1552-1557.
